Fundraising Fox
/Companies
Sign in

Radar Therapeutics

17 employees on LinkedIn · 6 known investors

Find your way into Radar Therapeutics

Sign up to see every warm intro you have to Radar Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Radar Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells. The company applies synthetic biology, single-cell transcriptomic data, RNA-editing enzymes, and logic gates to create "smart" mRNA therapies for difficult-to-treat diseases.

AI & Machine LearningBiotechDeep Tech

Investors · 6

NFXlisted by NFXSan Francisco · $250K – $5M

How we know: a partner's Signal profile · Not right? Tell us

Pioneerlisted by PioneerToronto, Ontario

How we know: pioneerfund.vc · Not right? Tell us

StartXlisted by StartXStanford · $10K – $1M

How we know: StartX's portfolio page · Not right? Tell us

The 23 Fundlisted by The 23 Fund

How we know: The 23 Fund's portfolio page · Not right? Tell us

KdT VenturesreportedAustin · $500K – $3M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$13.4M disclosed across 1 of 2 rounds · 2024

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

4 people who came through Radar Therapeutics went on to found or lead other companies.

Romesh SubramanianIndependent Board MemberFounded RaNA Therapeutics +2Andrew FraleyBoard Observer & Chief Innovation & Strategy Officer (Fractional)Founded Korro Bio +1Omri DroryBoard MemberFounded Renewal BioShannon DahlStrategic Advisor to CEOFounded Humacyte

In the news

Radar Therapeutics Raises $13.4M in Seed Fundingfinsmes.com · May 2024

Frequently asked questions

What does Radar Therapeutics do?
Radar Therapeutics develops precision-expressed mRNA-based therapeutics using its RADAR platform, which reads a cell's RNA profile in real time to activate genetic payloads only in targeted cells and avoid effects in non-target cells. The company applies synthetic biology, single-cell transcriptomic data, RNA-editing enzymes, and logic gates to create "smart" mRNA therapies for difficult-to-treat diseases.
Who are Radar Therapeutics's investors?
Radar Therapeutics's investors include BEVC, NFX, Pioneer, StartX, The 23 Fund, KdT Ventures.
How much funding has Radar Therapeutics raised?
Radar Therapeutics has disclosed $13.4M raised across 1 of its 2 known rounds.